MYRIP (myosin VIIA and Rab interacting protein) is a Rab27A effector protein that functions as a critical regulator of secretory organelle trafficking and exocytosis. Mechanistically, MYRIP serves as a molecular bridge linking Rab27A-containing secretory granules and Weibel-Palade bodies (WPBs) to the cortical actin cytoskeleton 1. The protein mediates this connection through two independent functional domains: one binding to Rab27A and another directly interacting with F-actin filaments 2. Importantly, MYRIP's actin-binding capacity, rather than its myosin Va binding, plays the dominant role in regulating organelle trafficking and exocytosis 3. MYRIP also recruits myosin Va to secretory granules and functions as a scaffold linking them to the plasma membrane, promoting their immobilization and attachment 4. In pancreatic beta-cells, MYRIP is essential for insulin secretion in response to secretagogues 5, while in endothelial cells it negatively regulates von Willebrand factor release by anchoring WPBs to peripheral actin 6. Clinically, MYRIP variants are associated with left ventricular hypertrophy susceptibility in African ancestry populations, with MYRIP knockdown reducing expression of hypertrophic gene markers 7.